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Pars plana vitrectomy and silicone oil tamponade for
acute endophthalmitis treatment
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Purpose: To evaluate the outcomes of pars plana vitrectomy and silicone
oil injection for the treatment of infectious endophthalmitis. Methods: 35
cases of endophthalmitis secondary to phacoemulsification (20 patients),
trabeculectomy (8 patients), perforating trauma (2 patients), trauma (2
patients), corneal transplantation (1 patient), vitrectomy (1 patient) and
corneal ulceration (1 patient) were retrospectively studied. Patients were
separated into two groups: Group 1 (n=24): intravitreal antibiotic injection,
associated with topical and oral antibiotics; Group 2 (n=11): vitrectomy
with intravitreal antibiotic injection and silicone oil injection. The follow-
up ranged from 1 to 48 months (mean of 16 months). Results: From 24
patients in group 1, 11 patients (45.83%), had infection controlled with
intravitreal antibiotic injection only; 13 patients (54.15%) regressed to
uncontrolled endophthalmitis, in which two patients (8.33%) were
submitted to evisceration and one patient (4.16%) had corneal melting.
The remaining 10 patients (41.66%) with uncontrolled endophthalmitis
were submitted to pars plana vitrectomy and silicone oil injection. Six
patients (25%) from Group I had retinal detachment during the first month
of follow-up and also required pars plana vitrectomy and silicone oil
injection. In Group 2 patients (n=11), all of them had controlled infection
at the first procedure. In one case (9.09%), a severe proliferatative vitreo-
retinopathy induced loss of vision. Conclusion: These results suggest
that silicone oil tamponade might be beneficial in the treatment strategy
of infectious endophthalmitis.
ABSTRACT
INTRODUCTION
Endophthalmitis is most commonly reported after cataract surgery but
may occur after any intraocular procedure, after trauma, or from endoge-
nous sources. The incidence of endophthalmitis after cataract surgery
varies according to the surgical technique, but in recent large series, it has
ranged from 0.04% to 0.13%(1-4). Endophthalmitis after filtering surgery is
probably the second most commonly encountered etiologic category.
Because of its typically delayed onset, the exact incidence is more dif-
ficult to ascertain. With longer follow-up, bleb-associated endophthal-
mitis may occur in at least 1% of patients and has been described in up to
1.7% of eyes per year when antimetabolites are used(2,5-6). This incidence
of endophthalmitis is even higher when the bleb is constructed infe-
riorly(5-6). The treatment of endophthalmitis has historically involved
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multiple routes of antibiotic administration, including intra-
vitreal, systemic, topical, and subconjunctival(7). With the
advent of pars plana vitrectomy techniques, vitrectomy com-
bined with injection of intravitreal antibiotics became the
standard treatment for virtually all forms of endophthalmi-
tis(8-9). Favorable sensitivity profiles and acceptably low to-
xicity rates have resulted in vancomycin and ceftazidime (more
recently supplanting aminoglycosides) becoming a widely
utilized regimen of intravitreal antibiotics(10-12). Topical and
subconjunctival antibiotics are also commonly used.
The role of pars plana vitrectomy (PPV) in the treatment of
endophthalmitis is controversial. The results of the Endoph-
thalmitis Vitrectomy Study (EVS) suggested that patients, with
a visual acuity of light perception, have better prognosis if
treated with immediate PPV(13). Silicone oil has been used in-
creasingly in vitreoretinal surgery as an internal tamponade,
with a significant improvement of the anatomical and visual
outcome in many bad prognosis cases(14). The dynamics of sili-
cone involve surface tension and viscosity, but also limit the
free movements of aqueous humor in the eye. No microorga-
nisms seem to be able to penetrate and develop within this inert
material(15). Moreover, antibacterial properties of silicone oil
have been recently reported in vitro(16). Since the early nineties,
vitreoretinal surgeons have used silicone oil in some cases of
endophthalmitis with extensive retinal damage as intraocular
tamponade in order to prevent retinal detachment(16-21).
The purpose of this retrospective study was to compare
the results of treating endophthalmitis using 3 options: 1) in-
travitreal antibiotic injection (IVAB) 2) vitrectomy with
injection of silicone oil and antibiotics as a first treatment 3)
vitrectomy with injection of silicone oil and antibiotics as a
second treatment after the failure of IVAB.
METHODS
Thirty-five charts from thirty-five patients with endoph-
thalmitis treated at HORP-Hospital do Olho de Rio Preto-São
Paulo-Brazil, between January 2001 and 2006 were reviewed.
The clinical diagnosis was based on the standard sign
and symptoms of endophthalmitis: pain, loss of vision, lid
edema, conjunctival chemosis and injection, corneal ede-
ma, anterior chamber flare, hypopyon, and vitreous opacifi-
cation. Culture studies of vitreous samples were performed
in all cases.
The patients were separated into two groups:
Group 1 (24 patients): Intravitreal antibiotic injection
(IVAB), vancomycin 1 mg/0.1 ml, ceftazidime 2.25 mg/0.1 ml,
dexamethasone 0.4 mg/0.1 ml). Periocular (subconjunctival)
vancomycin 25 mg, ceftazidime 100 mg, dexamethasone 12
to 24 mg. Topical (started on first postoperative day) van-
comycin 50 mg/ml q 1 hour, ceftazidime 50 mg/ml q 1 hour.
Topical steroids and cycloplegics. Systemic: vancomycin 1 g
IV q 12 hours, ceftazidime 1 g IV q 12 hours or ciprofloxacin
750 mg p.o. q 12 hours for susceptible organisms.
Group 2 (11 patients): Pars plana vitrectomy (PPV) with
injection of silicone oil (SOI) and antibiotics as a first treat-
ment. The patients were submitted to standard three-port pars
plana vitrectomy using ACCURS vitrectomy machine
(Alcon, Fort Worth, Texas, USA). Initially, the central vi-
treous was removed (core vitrectomy), with later peeling of
dense epiretinal membranes. Next, the remaining traction
points were identified; including those of hard removal, i.e.,
star folds with intraretinal fibrosis. At those sites, instead of
removing membranes with the use of forceps, a puncture
retinotomy was performed using endodiathermy. After rela-
xing the traction areas, subretinal fluid was aspirated with a
long extensible silicone-tipped cannula, taking advantage of
the retinotomy. After this procedure, we checked whether
the entire retina was attached and, if this was not the case,
additional retinotomies were made to release the traction,
and a new aspiration of subretinal fluid was performed. After
the retina was entirely flattened against the retinal pigment
epithelium RPE, photocoagulation was applied surrounding
all retinal breaks and along the entire edge of the puncture
retinotomies. At the end of the procedure silicone oil was
injected into the eye with IVAB.
The follow-up ranged from 1 to 48 months (mean=16
months). Anatomical status and visual outcome were recor-
ded in order to compare the prognosis of different approa-
ches.
 The criteria for control of infection were: a) absorption of
hypopyon, b) decrease or absence of cells and flare in the
anterior chamber and vitreous, c) improvement of symptoms
such as pain, d) improvement in congestion and conjunctival
hyperemia and eyelids.
RESULTS
Clinical characteristics of all patients are shown in tables
1 and 2.
The average age of the patients was 66.82 years (range,
12-85 years). A vitreous positive culture was found in 12
cases (34.28%). Of these 12 cases, 6 (50%) were due to Sta-
phylococcus epidermidis: 2 (16.66%) cases were due to Strep-
tococcus sp; 1 case each was due to Staphylococcus sapro-
fiticus, Staphylococcus aureus and Morganella morganii.
In Group 1, the average visual acuity ranged from 20/30
to light perception (before treatment) and 20/60 to light
perception (after treatment). Nine patients (37.5%) had wor-
sening of visual acuity, 10 patients (41.6%) improved and 5
patients (20.83%) did not change.
In Group 2, the average visual acuity ranged from 20/40 to
light perception (before treatment) and 20/30 to light percep-
tion (after treatment). One patient (9.09%) showed worsening
of visual acuity, 5 patients (45.45%) improved and 5 patients
(45.45%) did not change.
From 24 patients in Group 1, 11 (45.83%), had infection
control with IVAB only; 13 patients (54.15%) progressed to
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Table 1. Clinical characteristics of group 1
Patient Age Surgery Time Infection Second Infection Compli- Initial Final Culture Follow-
(y) presen- control treatment control cation VA VA up
tation (1) (2) months
01 63 CE 30 d no PPV+sil oil yes - CF 1m CF 1m - 5
02 75 CE 4 d no PPV+sil oil yes RD HM HM Strep. sp 14
03 78 CE 5 d no PPV+sil oil yes - HM LP Strep.viridans 4
04 66 CE 3 d no PPV+sil oil yes RD HM HM - 6
05 60 CE - no AC wash yes Melting LP LP - 24
06 69 CE 30 d no PPV+sil oil yes RD HM LP - 2
07 67 CE 5 d yes - - - LP 20/80 - 8
08 12 Trauma 3 d no Evisceration - - LP NLP Bacillus G + 24
09 30 Trauma 3 d no PPV+sil oil yes - HM HM Staph. 30
saprofiticus
10 79 CE 5 d no PPV+sil oil yes - HM 20/30 Staph. aureus. 24
11 85 FM 4 y yes - - - LP HM - 12
12 77 CE 10 d no PPV+sil oil yes - HM 20/200 - 8
13 53 FM 2 y no - - RD HM NLP - 48
14 73 CE 15 d no PPV+sil oil yes - 20/40 20/30 Morganella 32
morganii
15 81 CE 10 d no PPV +sil oil yes - HM CF 60 cm Staph. epid. 7
16 81 FM 2 y no PPV+sil oil yes - 20/100 HM - 2
17 69 PCIOL 6 d yes - - - CF 60 cm 20/30 - 36
18 65 CE 15 d yes - - - CF 20 cm 20/60 - 6
19 78 FM 2 y yes - - - 20/60 20/100 - 17
20 64 FM 5 y no PPV+sil oil yes - LP HM - 1
21 66 CE 4 d no Evisceration - - NLP NLP Staph. epid. 13
22 77 CE 120 d no PPV+sil oil yes - HM CF 30 cm - 32
23 51 CE 1 d no PPV+sil oil yes - HM 20/200 - 20
24 83 FM 1 y no PPV+sil oil yes RD HM LP - 7
VA= visual acuity; NLP= non light perception; LP= light perception; HM= hand motions; CF= counting fingers; AC= anterior chamber; Staph.= Staphylococcus; epid.=
epidermidis;   Strep.= Streptococcus; CE= cataract extraction; PCIOL= posterior chamber intraocular lens; FM= filtering surgery; d= days; y= years; PPV= pars plana
vitrectromy; sil oil= silicone oil; RD= retinal detachment
Table 2. Clinical characteristics of group 2
Patient Age Surgery Presentation Initial Final Culture Follow-up
(years) VA VA months
25 79 CE 4 days HM 20/60 - 12
26 59 CE 30 days 20/30 20/80 - 4
27 62 CE 5 days NLP NLP - 48
28 73 FM 1 year HM NLP Staph. epid. 48
29 73 FM 1 year HM HM - 2
30 79 TPC 60 days HM CF 10 cm Staph. epid. 24
31 71 CE 8 days HM HM - 5
32 57 CE 10 days LP CF 60 cm - 7
33 56 Fungal keratitis 60 days LP LP - 12
34 66 CE 6 days HM HM Staph. epid. 6
35 62 CE 3 years CF 1 m 20/400 Staph. epid. 2
VA= visual acuity; NLP= non light perception; LP= light perception; HM= hand motions; CF= counting fingers; Staph. epi.= Staphylococcus epidermidis; CE= cataract
extraction; PCIOL= posterior chamber intraocular lens; FM= filtering surgery; TPC
uncontrolled endophthalmitis, in which two patients (8.33%)
were submitted to evisceration and one patient (4.16%) had
corneal melting. The remaining 10 patients (41.66%) with
uncontrolled endophthalmitis were submitted to PPV and
SOI. Six patients (25%) from Group I had retinal detachment
during the first month of follow-up and also required PPV and
SOI. In Group 2 patients (n=11), all of them had controlled
infection on the first procedure. In one case (9.09%), a severe
proliferatative vitreoretinopathy (PVR) induced loss of vision
(NLP).
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DISCUSSION
 The relationship between the use of silicone oil and endoph-
thalmitis has been little discussed. Endophthalmitis is considered
one of the most devastating complications of ophthalmic
surgery. The incidence of endophthalmitis after cataract surgery
ranges from 0.04 to 0.13%(22-25). And after vitrectomy surgery
from 0.046 to 0.07%(12,26). The incidence of endophthalmitis after
vitrectomy where silicone oil was used is more rare with only 2
cases reported in the literature with positive culture(3,20). Other
authors reported 2 cases of endophthalmitis in patients under-
going surgery with silicone oil, but the culture was negative and
because the inflammatory reaction was probably consequent to
the components of silicone oil(7-10).
The likely antimicrobial potential of silicone oil has re-
cently been reported. The authors demonstrated in vitro that
the silicone oil decreases the proliferation of bacteria respon-
sible for endophthalmitis(18). In the eyes of humans, the ac-
tion of silicone oil against the microorganisms could be
explained by the following mechanisms: 1) the silicone oil
can be toxic to the bacteria, as suggested in in vitro experi-
ments, however this hypothesis still needs to be confirmed by
more experiments; 2) the silicone oil is highly hydrophobic
with a high interfacial tension and thus presents a low per-
meability to the passage of cells and bacteria(8). Therefore,
this limits the space for the movement of infectious agents
and keeps them in touch with the ciliary body and vessels of
the retina, which can improve the effectiveness of the defense
mechanisms, by a high concentration of biochemical media-
tors, antibodies and inflammatory cells within an aqueous
compartment of the vitreous cavity.
In the literature, endophthalmitis is suspected to increase
the risk of retinal detachment. EVS reported 20 cases of retinal
detachment in a series of 420 patients, 6 in the vitrectomy
group (2.8% of 218 patients) and 14 in the non vitrectomy
group (6.9% of 202 patients). Other authors(17) described reti-
nal detachment to occur in 21% (7/34) of endophthalmitis
patients treated with vitrectomy and intraocular antibiotics.
In the other study a similar complication rate was descri-
bed with 26% retinal detachments (9/34): 8 patients (23%) in
the non silicone groups (1 and 2), 1 patient (7%) in the silicone
groups (3 and 4). The authors postulated that retinal detach-
ment could be either the result of surgical complications or be
provoked by the changes in retina and vitreous as a reaction
to severe ocular inflammation(21).
Our series showed that in Group 1, 11 patients (45.83%),
had infection control with intravitreal injections only. Howe-
ver, 16 (66.66%) patients required pars plana vitrectomy and
silicone oil, 10 patients (41.66%) had uncontrolled endoph-
thalmitis and 6 (25%) had retinal detachment. Two patients
(8.33%) were submitted to evisceration and one patient (4.16%)
had corneal melting.
In Group 2, all patients had controlled infection at the
first procedure and did not need further surgery, except for
removal of silicone oil three months later. In one case
(9.09%), a severe PVR induced loss of vision (NLP) but the
cosmetic results were acceptable.
Many authors also reported that concurrent endophthalmitis
and retinal detachment have a poor visual and anatomical out-
come, especially when retinal detachment is an intraoperative
complication(2,11,15,19-20). The use of silicone oil can therefore help
in controlling the infectious process and reduce the risk of retinal
detachment, contributing to a better outcome in the treatment of
endophthalmitis. After control of the infectious and inflammatory
process the silicone oil can be removed, which in our study was
conducted on average 3 months after the procedure.
CONCLUSION
This retrospective study suggests that silicone oil might be
beneficial in the treatment strategy of severe endophthalmitis.
Patients treated with silicone oil have a better control of infec-
tion, better anatomical stabilization and better final visual
acuity. Additionally, silicone oil seems to reduce the risk of
retinal detachment and the need for additional procedures.
The role of silicone oil in the treatment of endophthal-
mitis should be better assessed by a prospective, controlled
study and with the highest number of cases to confirm the
evidence of this study.
RESUMO
Objetivo: Avaliar os resultados da vitrectomia pars plana com
tamponamento com óleo de silicone no tratamento de endof-
talmite aguda. Métodos: Trinta e cinco pacientes com endoftal-
mite, sendo 20 secundário à facoemulsificação, 8 por trabecu-
lectomia, 2 por trauma perfurante, 2 por trauma, 1 por trans-
plante de córnea, 1 por vitrectomia, e 1 por úlcera de córnea,
foram estudados retrospectivamente. Os pacientes foram separa-
dos em dois grupos. Grupo 1 (n=24): injeção de antibiótico
intravítreo (AIV), associado com antibióticos oral e sistêmico;
Grupo 2 (n=11): vitrectomia com AIV e óleo de silicone. O
seguimento variou de 1 a 48 meses (média de 16 meses). Resul-
tados: Dos 24 pacientes no Grupo 1, 11 (45,83%) tiveram con-
trole da infecção apenas com injeção AIV, 13 (54,15%) não
controlaram a endoftalmite, sendo que, dois destes (8,33%) fo-
ram submetidos à evisceração e um (4,16%) evoluiu para “mel-
ting” corneano. Os outros 10 (41,66%) pacientes foram submeti-
dos à vitrectomia pars plana e óleo de silicone. Seis pacientes
(25%) do Grupo 1 tiveram descolamento de retina e também
necessitaram de vitrectomia pars plana e óleo de silicone. No
Grupo 2 (n=11), todos tiveram controle da infecção no primeiro
procedimento e não necessitaram de mais intervenções, exceto
pela remoção do óleo de silicone três meses depois. Conclusão:
Os resultados sugerem que o tamponamento por óleo de silico-
ne parece ser benéfico na estratégia de tratamento da endof-
talmite infecciosa aguda.
Descritores: Vitrectomia; Óleo de silicone; Endoftalmite
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